Intersect ENT, Inc
XENT
XENT was delisted on the 12th of May, 2022.
136 hedge funds and large institutions have $927M invested in Intersect ENT, Inc in 2019 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 55 increasing their positions, 40 reducing their positions, and 19 closing their positions.
525% more call options, than puts
Call options by funds: $18.3M | Put options by funds: $2.93M
38% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 40
10% more capital invested
Capital invested by funds: $842M → $927M (+$84.6M)
0% more funds holding
Funds holding: 136 → 136 (0)
0% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 19
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$18.6M |
| 2 |
Morgan Stanley
New York
|
+$5.47M |
| 3 |
William Blair Investment Management
Chicago,
Illinois
|
+$4.29M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$4.25M |
| 5 |
OCM
Osterweis Capital Management
San Francisco,
California
|
+$3.87M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$43M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$15.8M |
| 3 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$7.99M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$6.19M |
| 5 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$3.29M |
XENT Hedge Fund Activity: Q1 2019 in Review
136 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q1 2019, worth a combined $927M — up 10% from $842M a quarter earlier.
Fund positioning in XENT was balanced in Q1 2019: 19 funds opened new positions, 19 closed out, 55 added to existing stakes and 40 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $18.6M. The largest seller was Wellington Management Group, cutting an estimated $43M.
- 136 institutional investors held Intersect ENT, Inc (XENT) as of Q1 2019, unchanged from Q4 2018.
- Funds reported $927M of Intersect ENT, Inc stock for Q1 2019, up 10% quarter-over-quarter.
- 19 funds opened new Intersect ENT, Inc positions in Q1 2019 and 19 closed out, a net change of 0 holders.
- The largest Intersect ENT, Inc buyer in Q1 2019 was Fidelity Investments, an estimated $18.6M added.
- The largest Intersect ENT, Inc seller in Q1 2019 was Wellington Management Group, an estimated $43M sold.
Based on aggregated 13F filings for Q1 2019.